Posted inStock Dow futures slip 214 points amid Fed jitters: 5 things to know before Wall Street opens Dow futures were under pressure on Friday, falling about 214 points, roughly 0.5% as investors… November 14, 2025 Posted inStock How Caterpillar is emerging as an AI giant: Wells Fargo Caterpillar shares may still have room to climb, according to Wells Fargo, which initiated coverage… November 14, 2025 Posted inStock Goldman Sachs says this AI name is a better pick than Palantir stock for 2026 Palantir Technologies Inc (NASDAQ: PLTR) has pulled back in recent days amidst a broader sell-off… November 14, 2025 Posted inStock MSTR stock price analysis as mNAV drops below 1 The MSTR stock price has collapsed this year, moving from the year-to-date high of $456… November 14, 2025 Posted inStock The next wave of AI-driven cost cuts: Vista and Meta send clear signals this week The private equity and big tech playbooks are converging on a singular strategy: replace expensive… November 14, 2025 Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock How Caterpillar is emerging as an AI giant: Wells Fargo Caterpillar shares may still have room to climb, according to Wells Fargo, which initiated coverage… November 14, 2025 Posted inStock Goldman Sachs says this AI name is a better pick than Palantir stock for 2026 Palantir Technologies Inc (NASDAQ: PLTR) has pulled back in recent days amidst a broader sell-off… November 14, 2025 Posted inStock MSTR stock price analysis as mNAV drops below 1 The MSTR stock price has collapsed this year, moving from the year-to-date high of $456… November 14, 2025 Posted inStock The next wave of AI-driven cost cuts: Vista and Meta send clear signals this week The private equity and big tech playbooks are converging on a singular strategy: replace expensive… November 14, 2025 Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock Goldman Sachs says this AI name is a better pick than Palantir stock for 2026 Palantir Technologies Inc (NASDAQ: PLTR) has pulled back in recent days amidst a broader sell-off… November 14, 2025 Posted inStock MSTR stock price analysis as mNAV drops below 1 The MSTR stock price has collapsed this year, moving from the year-to-date high of $456… November 14, 2025 Posted inStock The next wave of AI-driven cost cuts: Vista and Meta send clear signals this week The private equity and big tech playbooks are converging on a singular strategy: replace expensive… November 14, 2025 Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock MSTR stock price analysis as mNAV drops below 1 The MSTR stock price has collapsed this year, moving from the year-to-date high of $456… November 14, 2025 Posted inStock The next wave of AI-driven cost cuts: Vista and Meta send clear signals this week The private equity and big tech playbooks are converging on a singular strategy: replace expensive… November 14, 2025 Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock The next wave of AI-driven cost cuts: Vista and Meta send clear signals this week The private equity and big tech playbooks are converging on a singular strategy: replace expensive… November 14, 2025 Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inPolitics SCOOP: Dept of Energy says it saved $700M in Trump’s first 100 days by cutting ‘wasteful’ programs In President Donald Trump’s first 100 days, the Department of Energy says it has saved… April 28, 2025
Posted inStock PepeX price prediction as Nvidia, Amazon tout continued AI demand Despite a massive hit to AI stocks in recent weeks due to continued uncertainty coming… April 27, 2025
Posted inStock PayPal stock price analysis: buy, sell, or hold ahead of earnings? PayPal stock price on Tuesday, when it publishes its first-quarter financial results, will show whether… April 27, 2025
Posted inStock Estee Lauder stock forms giant wedge: is a rebound coming? Estee Lauder stock price has been in a free fall in the past few years… April 27, 2025
Posted inStock Top 3 catalysts for SPY, DIA, and QQQ ETFs this week The SPDR S&P 500 ETF (SPY) has bounced back in the past few weeks, rising… April 27, 2025
Posted inStock Booking, Airbnb, and Expedia stocks forecasts ahead of earnings Travel and hospitality giants such as Booking Holdings (BKNG), Airbnb (ABNB), and Expedia (EXPE) will… April 27, 2025
Posted inStock Long CALM: Cal-Maine Foods Poised for Uptrend Following Strong Earnings and Technical Breakout April 27, 2025
Posted inStock Long LYTS: LYTS Rebounds from Key Support Amid Strong Display Solutions Growth April 27, 2025
Posted inStock Alphabet earnings beat, but analysts say the numbers may not add much to the stock: read why The post Alphabet earnings beat, but analysts say the numbers may not add much to… April 27, 2025
Posted inStock Grupo Mexico reports 17% rise in Q1 net income on higher metal prices, cost efficiency Grupo Mexico, South America’s biggest mining and transport conglomerate, posted a 17% increase in first-quarter… April 26, 2025